• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.

作者信息

Strocchio Luisa, Gurnari Carmelo, Santoro Nicola, Putti Maria C, Micalizzi Concetta, Zecca Marco, Cuccurullo Rosanna, Girardi Katia, Diverio Daniela, Testi Anna M, Lo-Coco Francesco, Locatelli Franco

机构信息

Department of Paediatric Haematology/Oncology, IRCCS Bambino Gesù Children's Hospital, Rome, Italy.

University of Tor Vergata, Rome, Italy.

出版信息

Br J Haematol. 2019 Apr;185(2):360-363. doi: 10.1111/bjh.15507. Epub 2018 Jul 20.

DOI:10.1111/bjh.15507
PMID:30028005
Abstract
摘要

相似文献

1
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia.三氧化二砷与全反式维甲酸联合治疗儿童急性早幼粒细胞白血病
Br J Haematol. 2019 Apr;185(2):360-363. doi: 10.1111/bjh.15507. Epub 2018 Jul 20.
2
Tolerance to arsenic trioxide combined with all-trans-retinoic acid in children with acute promyelocytic leukaemia in France.法国儿童急性早幼粒细胞白血病对三氧化二砷联合全反式维甲酸的耐受性
Br J Haematol. 2020 Jan;188(1):170-173. doi: 10.1111/bjh.16364. Epub 2019 Dec 6.
3
Oral arsenic plus retinoic acid versus intravenous arsenic plus retinoic acid for non-high-risk acute promyelocytic leukaemia: a non-inferiority, randomised phase 3 trial.口服砷剂联合维甲酸与静脉用砷剂联合维甲酸治疗非高危急性早幼粒细胞白血病的非劣效性、随机、3 期临床试验。
Lancet Oncol. 2018 Jul;19(7):871-879. doi: 10.1016/S1470-2045(18)30295-X. Epub 2018 Jun 5.
4
Arsenic trioxide and all-trans retinoic acid (ATRA) treatment for acute promyelocytic leukemia in all risk groups: study protocol for a randomized controlled trial.三氧化二砷与全反式维甲酸（ATRA）治疗所有风险组急性早幼粒细胞白血病：一项随机对照试验的研究方案
Trials. 2018 Sep 5;19(1):476. doi: 10.1186/s13063-018-2812-3.
5
Younger age at diagnosis of acute promyelocytic leukaemia is associated with better long-term cognitive functioning.急性早幼粒细胞白血病诊断时年龄较小与较好的长期认知功能相关。
Br J Haematol. 2020 Sep;190(5):e304-e307. doi: 10.1111/bjh.16877. Epub 2020 Jun 18.
6
Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group.三氧化二砷在治疗新诊断的急性早幼粒细胞白血病中是必需的。法国-比利时-瑞士 APL 组对一项随机试验（APL2006）的分析。
Haematologica. 2018 Dec;103(12):2033-2039. doi: 10.3324/haematol.2018.198614. Epub 2018 Jul 19.
7
Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.阿糖胞苷在全反式维甲酸和三氧化二砷联合治疗儿童急性早幼粒细胞白血病中的作用：一项随机对照试验。
BMC Cancer. 2018 Apr 3;18(1):374. doi: 10.1186/s12885-018-4280-2.
8
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial.三氧化二砷和全反式维甲酸治疗所有风险组急性早幼粒细胞白血病（AML17）：一项随机、对照、3 期临床试验的结果。
Lancet Oncol. 2015 Oct;16(13):1295-305. doi: 10.1016/S1470-2045(15)00193-X. Epub 2015 Sep 14.
9
Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.砷剂联合全反式维 A 酸治疗儿童急性早幼粒细胞白血病：来自 CCLG-APL2016 方案研究的报告。
J Clin Oncol. 2021 Oct 1;39(28):3161-3170. doi: 10.1200/JCO.20.03096. Epub 2021 Jun 2.
10
Intravenous arsenic trioxide and all-trans retinoic acid as front-line therapy for low-risk acute promyelocytic leukemia.静脉注射三氧化二砷和全反式维甲酸作为低危急性早幼粒细胞白血病的一线治疗。
Expert Rev Hematol. 2019 Feb;12(2):81-87. doi: 10.1080/17474086.2019.1562332. Epub 2019 Jan 7.

引用本文的文献

1
Induction treatments with and without addition of one dose anthracycline to all-trans retinoid acid and arsenic in pediatric non-high-risk acute promyelocytic leukemia: study protocol for a randomized controlled trial.在儿童非高危急性早幼粒细胞白血病中，全反式维甲酸和砷剂治疗基础上添加或不添加一剂蒽环类药物的诱导治疗：一项随机对照试验的研究方案
Trials. 2024 Dec 18;25(1):819. doi: 10.1186/s13063-024-08664-y.
2
Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale.急性早幼粒细胞白血病的无化疗治疗：一个革命性故事的儿科视角
Front Oncol. 2023 Apr 14;13:1135350. doi: 10.3389/fonc.2023.1135350. eCollection 2023.
3
PRMT5-mediated RNF4 methylation promotes therapeutic resistance of APL cells to AsO by stabilizing oncoprotein PML-RARα.
PRMT5 介导的 RNF4 甲基化通过稳定癌蛋白 PML-RARα 促进 APL 细胞对 AsO 的治疗抵抗。
Cell Mol Life Sci. 2022 May 27;79(6):319. doi: 10.1007/s00018-022-04358-3.
4
Has Hematopoietic Stem Cell Transplantation a Role in the Treatment of Children and Adolescents with Acute Promyelocytic Leukemia?造血干细胞移植在儿童和青少年急性早幼粒细胞白血病治疗中起作用吗？
Mediterr J Hematol Infect Dis. 2022 May 1;14(1):e2022038. doi: 10.4084/MJHID.2022.038. eCollection 2022.
5
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO.全反式维甲酸/三氧化二砷治疗小儿急性早幼粒细胞白血病中严重分化综合征的挑战性管理
Mediterr J Hematol Infect Dis. 2022 Mar 1;14(1):e2022027. doi: 10.4084/MJHID.2022.027. eCollection 2022.
6
Long non-coding RNAs and microRNAs as crucial regulators in cardio-oncology.长链非编码RNA和微小RNA作为心脏肿瘤学中的关键调节因子。
Cell Biosci. 2022 Mar 4;12(1):24. doi: 10.1186/s13578-022-00757-y.
7
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy.儿童急性早幼粒细胞白血病：精准医学和无化疗治疗的典范。
Int J Mol Sci. 2021 Jan 11;22(2):642. doi: 10.3390/ijms22020642.
8
Acute Promyelocytic Leukemia: A History over 60 Years-From the Most Malignant to the most Curable Form of Acute Leukemia.急性早幼粒细胞白血病：60 多年的历程——从最恶性的急性白血病形式到最可治愈的形式
Oncol Ther. 2019 Jun;7(1):33-65. doi: 10.1007/s40487-018-0091-5. Epub 2019 Feb 5.
9
The genomics of acute myeloid leukemia in children.儿童急性髓系白血病的基因组学研究。
Cancer Metastasis Rev. 2020 Mar;39(1):189-209. doi: 10.1007/s10555-020-09846-1.